This funding supports the renewal of the Integrated Islet Distribution Program to provide critical human islet resources to biomedical researchers. The program establishes partnerships with qualified islet isolation facilities to distribute human islets, facilitating research on human islet biology and development of new therapies for type 1 diabetes prevention and treatment. Clinical trials are not allowed under this cooperative agreement.
Eligible applicants include organizations specified in the Additional Information on Eligibility section, with a focus on those qualified to continue the Integrated Islet Distribution Program. Specific eligibility details require review.
